Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

3
results for

"Yongsoo Kim"

Article category

Keywords

Publication year

"Yongsoo Kim"

Original Article

Hepatic neoplasm

Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume
Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim
Clin Mol Hepatol 2015;21(1):71-79.
Published online March 25, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.1.71
Background/Aims

To investigate sequential changes in laboratory markers after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) and the relationship of these changes to the severity of the underlying liver disease.

Methods

This retrospective analysis included 65 patients (44 males, 21 females) who underwent RFA of HCC. Hematologic and biochemical markers were assessed at the pre-RFA period and 1 day, 2-3 days, and 1-2 weeks after RFA. We classified the subjects into two groups: Child-Pugh A (n=41) and Child-Pugh B (n=24). The ablative margin volume (AMV) of each patient was measured. We analyzed the changes in laboratory profiles from the baseline, and investigated whether these laboratory changes were correlated with the AMV and the Child-Pugh classification.

Results

Most of the laboratory values peaked at 2-3 days after RFA. AMV was significantly correlated with changes in WBC count, hemoglobin level, and serum total bilirubin level (Pearson's correlation coefficient, 0.324-0.453; P<0.05). The alanine aminotransferase (ALT) level varied significantly over time (P=0.023).

Conclusions

Most of the measured laboratory markers changed from baseline, peaking at 2-3 days. The ALT level was the only parameter for which there was a significant difference after RFA between Child-Pugh A and B patients: it increased significantly more in the Child-Pugh A patients.

Citations

Citations to this article as recorded by  Crossref logo
  • Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study
    Ying Zhang, Kazushi Numata, Kento Imajo, Haruki Uojima, Akihiro Funaoka, Satoshi Komiyama, Katsuaki Ogushi, Makoto Chuma, Kuniyasu Irie, Shigehiro Kokubu, Masato Yoneda, Takashi Kobayashi, Hisashi Hidaka, Taito Fukushima, Satoshi Kobayashi, Manabu Morimot
    Hepatology Research.2024; 54(12): 1174.     CrossRef
  • Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liver function: A Pilot Study
    Feiqian Wang, Kazushi Numata, Satoshi Komiyama, Haruo Miwa, Kazuya Sugimori, Katsuaki Ogushi, Satoshi Moriya, Akito Nozaki, Makoto Chuma, Litao Ruan, Shin Maeda
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Hepatoprotective support during radiofrequency ablation in patients with colorectal liver metastases
    S. V. Vertyankin, O. M. Konopatskova
    Onkologiya. Zhurnal imeni P.A.Gertsena.2019; 8(5): 375.     CrossRef
  • Feasibility of Percutaneous Intrahepatic Split by Microwave Ablation (PISA) After Portal Vein Embolization for Hypertrophy of Future Liver Remnant: The Radiological Stage-1 ALPPS
    Alessandro Lunardi, Rosa Cervelli, Duccio Volterrani, Saverio Vitali, Carlo Lombardo, Giulia Lorenzoni, Laura Crocetti, Irene Bargellini, Daniela Campani, Luca Emanuele Pollina, Roberto Cioni, Davide Caramella, Ugo Boggi
    CardioVascular and Interventional Radiology.2018;[Epub]     CrossRef
  • 11,400 View
  • 115 Download
  • 3 Web of Science
  • Crossref
Liver Imagings

Hepatic neoplasm

Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid-enhanced liver MRI
Seung Hyun Kim, Woo Kyoung Jeong, Yongsoo Kim, Min Yeong Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh
Korean J Hepatol 2013;19(1):92-96.
Published online March 25, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.1.92

Citations

Citations to this article as recorded by  Crossref logo
  • Prediction of insufficient hepatic enhancement during the Hepatobiliary phase of Gd-EOB DTPA-enhanced MRI using machine learning classifier and feature selection algorithms
    Ji Su Ko, Jieun Byun, Seongkeun Park, Ji Young Woo
    Abdominal Radiology.2022; 47(1): 161.     CrossRef
  • Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma
    Yi-Di Chen, Ling Zhang, Zhi-Peng Zhou, Bin Lin, Zi-Jian Jiang, Cheng Tang, Yi-Wu Dang, Yu-Wei Xia, Bin Song, Li-Ling Long
    World Journal of Gastroenterology.2022; 28(31): 4399.     CrossRef
  • Comparison of Conventional Gadoxetate Disodium–Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion
    Yidi Chen, Yuwei Xia, Parag P. Tolat, Liling Long, Zijian Jiang, Zhongkui Huang, Qin Tang
    American Journal of Roentgenology.2021; 216(6): 1510.     CrossRef
  • Diagnostic Value of Gd‐EOB‐DTPA‐Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma
    Yidi Chen, Xiali Qin, Liling Long, Ling Zhang, Zhongkui Huang, Zijian Jiang, Chenhui Li
    Journal of Magnetic Resonance Imaging.2020; 51(6): 1755.     CrossRef
  • Cystic Degeneration of Hepatocellular Carcinoma Mimicking Mucinous Cystic Neoplasm
    Jangwon Lee, Namhee Lee, Hye Kyoung Yoon, Yeon Jae Lee, Sung Jae Park
    The Korean Journal of Gastroenterology.2019; 73(5): 303.     CrossRef
  • Quantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangioma
    Zhenpeng Peng, Chang Li, Tao Chan, Huasong Cai, Yanji Luo, Zhi Dong, Zi-Ping Li, Shi-Ting Feng
    Oncotarget.2017; 8(39): 65435.     CrossRef
  • Atypical Magnetic Resonance Imaging Findings in Hepatocellular Carcinoma
    Panayota S. Roumanis, Puneet Bhargava, Golnaz Kimia Aubin, Joon-Il Choi, Aram N. Demirjian, David A. Thayer, Chandana Lall
    Current Problems in Diagnostic Radiology.2015; 44(3): 237.     CrossRef
  • Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI
    Stefano Palmucci
    World Journal of Hepatology.2014; 6(7): 477.     CrossRef
  • JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
    Masatoshi Kudo, Osamu Matsui, Namiki Izumi, Hiroko Iijima, Masumi Kadoya, Yasuharu Imai, Takuji Okusaka, Shiro Miyayama, Kaoru Tsuchiya, Kazuomi Ueshima, Atsushi Hiraoka, Masafumi Ikeda, Sadahisa Ogasawara, Tatsuya Yamashita, Tetsuya Minami, Koichiro Yama
    Liver Cancer.2014; 3(3-4): 458.     CrossRef
  • Surveillance and Diagnostic Algorithm for Hepatocellular Carcinoma Proposed by the Liver Cancer Study Group of Japan: 2014 Update
    Masatoshi Kudo, Osamu Matsui, Namiki Izumi, Hiroko Iijima, Masumi Kadoya, Yasuharu Imai
    Oncology.2014; 87(Suppl. 1): 7.     CrossRef
  • The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase
    Woo Kyoung Jeong, Young Kon Kim, Kyoung Doo Song, Dongil Choi, Hyo Keun Lim
    Clinical and Molecular Hepatology.2013; 19(4): 360.     CrossRef
  • 11,409 View
  • 83 Download
  • 10 Web of Science
  • Crossref
MR imaging of hepatic lymphangioma
Woo Jung Choi, Woo Kyoung Jeong, Yongsoo Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh
Korean J Hepatol 2012;18(1):101-104.
Published online March 22, 2012
DOI: https://doi.org/10.3350/kjhep.2012.18.1.101

Citations

Citations to this article as recorded by  Crossref logo
  • Diagnosis of a Liver Lymphangioma Using Contrast-Enhanced Ultrasonography (CEUS): Single Case Report
    Elīza Marta Budava, Ieva Pūce, Kalvis Kaļva, Nauris Zdanovskis
    Reports.2026; 9(1): 59.     CrossRef
  • Endoscopic submucosal dissection in the treatment of adult cystic lymphangioma: A case report
    Luo-Wei Qu, Qiu-Xia Li, Wen-Ying Zhu, Min Kang
    World Journal of Gastrointestinal Surgery.2025;[Epub]     CrossRef
  • Extensive solitary lymphatic malformation of the liver in a child: a case report and literature review
    Anna Parmeggiani, Michelangelo Baldazzi, Filomena Carfagnini, Donatella Vivacqua, Rita Golfieri, Luigi Lovato, Laura Greco
    Radiology Case Reports.2022; 17(3): 427.     CrossRef
  • Benign focal liver lesions: The role of magnetic resonance imaging
    Marco Gatti, Cesare Maino, Davide Tore, Andrea Carisio, Fatemeh Darvizeh, Eleonora Tricarico, Riccardo Inchingolo, Davide Ippolito, Riccardo Faletti
    World Journal of Hepatology.2022; 14(5): 923.     CrossRef
  • Case report of solitary giant hepatic lymphangioma
    Hwan Hyo Lee, Seon Youl Lee
    Korean Journal of Hepato-Biliary-Pancreatic Surgery.2016; 20(2): 71.     CrossRef
  • Disorders of the lymphatic system of the abdomen
    A.R. Patil, S. Nandikoor, J. De Marco, R. Bhat, S. Shivakumar, G. Mallrajapatna
    Clinical Radiology.2016; 71(10): 941.     CrossRef
  • Clinical Analysis of Intraperitoneal Lymphangioma
    Qing Li, Dong Ji, Kang-Sheng Tu, Chang-Wei Dou, Ying-Min Yao
    Chinese Medical Journal.2015; 128(22): 3043.     CrossRef
  • Rare case of a solitary huge hepatic cystic lymphangioma
    Ya-Zhou Zhang
    World Journal of Clinical Cases.2013; 1(4): 152.     CrossRef
  • 12,299 View
  • 65 Download
  • Crossref